SCHEMBL20660587

SCHEMBL20660587

Cc1cc(C(F)(F)F)cc(C#N)c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.38
MAPT P10636 1/20 0.38
XBP1 P17861 1/20 0.38
AR P10275 11/20 0.38
POLB P06746 2/20 0.38
LMNA P02545 1/20 0.35
NCOA1 Q15788 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
ALOX5AP P20292 1/20 0.35
FEN1 P39748 1/20 0.35
MBOAT4 Q96T53 1/20 0.34
KIF11 P52732 1/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9730417 0.88 AR (0.39) ARALOX5APFEN1KIF11TSHR
SCHEMBL2370038 0.82 ALDH1A1 (0.44) ARLMNASMN1; SMN2ALOX5APFEN1
SCHEMBL18702757 0.82 POLB (0.59) HTTMAPTPOLBKIF11GABRA1
SCHEMBL23301575 0.81 AR (0.46) AR
SCHEMBL463526 0.81 ALOX5AP (0.40) ARALOX5APFEN1KIF11
SCHEMBL23503139 0.80 AR (0.40) ARKIF11TSHR
SCHEMBL23502945 0.79 AR (0.42) ARKIF11
SCHEMBL9581766 0.79 GABRP (0.42) ARPOLBLMNASMN1; SMN2GABRP
SCHEMBL27614060 0.79 PTPN5 (0.37) ARSMN1; SMN2ALOX5APFEN1MBOAT4
SCHEMBL9581992 0.79 ADRB2 (0.41) MAPTARALOX5APFEN1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258354-B2 AhR modulators IDEAYA BIOSCIENCES, INC. (US) 2025-03-25 US disclosed
EP-3749669-B3 AHR MODULATORS IDEAYA BIOSCIENCES INC (US) 2024-09-04 EP disclosed
CN-111683950-B AhR modulators 伊迪亚生物科学有限公司 2024-04-16 CN disclosed
EP-4219495-A1 AHR MODULATORS Ideaya Biosciences, Inc. (US) 2023-08-02 EP disclosed
EP-4219495-A1 AHR MODULATORS Ideaya Biosciences, Inc. (US) 2023-08-02 EP disclosed
EP-3749669-B1 AHR MODULATORS IDEAYA BIOSCIENCES INC (US) 2023-03-08 EP disclosed
US-20230039955-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2023-02-09 US disclosed
US-20230039955-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2023-02-09 US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 US disclosed
US-10815250-B2 AhR modulators IDEAYA BIOSCIENCES, INC. (US) 2020-10-27 US disclosed
CN-111683950-A AhR modulators 伊迪亚生物科学有限公司 2020-09-18 CN disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 WO disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 WO disclosed
US-20190270754-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2019-09-05 US disclosed
US-20190270754-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2019-09-05 US disclosed
WO-2019156987-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-08-15 WO disclosed
WO-2019156987-A1 AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-08-15 WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230039955-A1 AhR MODULATORS AHR, ARNT, RORB HTT 392/4885MAPT 4117/4885XBP1 207/4885
US-12258354-B2 AhR modulators AHR, ARNT, RORB HTT 387/4885MAPT 4102/4885XBP1 207/4885
US-10815250-B2 AhR modulators AHR, ARNT, RORB HTT 387/4885MAPT 4102/4885XBP1 207/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB HTT 355/4885MAPT 4185/4885XBP1 376/4885
US-20190270754-A1 AhR MODULATORS AHR, ARNT, RORB HTT 387/4885MAPT 4102/4885XBP1 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.